image

Authoritative Independent Monthly Share Selections Using Technical & Fundamental Analysis

Latest issue now available

PKL

March 2005

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

  • Epic Code:
  • PKL
  • Price:
  • 155p
Very respectable interims were masked by two one-off measures that caused analysts to pare back forecasts for this year and next, which caused the shares to be knocked down after previously reaching a high of 190p. For the six months ended 31 October, PKL achieved a 29% increase in turnover, which drove a 38% rise in pretax profit to £2.9m, while earnings were up 22% to 5.5p. The company noted that order books remained healthy, with the healthcare side seeing a 30% increase in enquiries. The reasons behind the earnings downgrade was first the expensing of upfront costs (£0.5m) to establish a start-up division and second, a change in the mix of healthcare sales from short-term sale to longer–term rent ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X